文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

清醒俯卧位用于COVID-19相关急性低氧性呼吸衰竭非插管患者:系统评价与Meta分析

Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis.
PubMed 文献 · Lancet Respir Med · 2022-03-16
一句话结论在COVID-19相关急性低氧性呼吸衰竭非插管患者中,清醒俯卧位可降低插管风险,尤其在接受先进呼吸支持或ICU治疗者;作者建议此类患者使用。

该系统评价与Meta分析检索2020年1月1日至2021年11月8日发表的英文RCT和观察性研究(对照组需含仰卧位),排除入组前或入组时已插管者、儿科患者(<18岁)及对照组不含仰卧位的研究。最终纳入29项研究:10项RCT(1985例)和19项观察性研究(2669例)。在10项RCT中,清醒俯卧位较仰卧位显著降低总体人群插管风险(RR 0.84 [95% CI 0.72-0.97]),在接受先进呼吸支持(经鼻高流量氧疗或无创通气)者(RR 0.83 [0.71-0.97])和ICU设置中(RR 0.83 [0.71-0.97])亦降低插管需求,但在接受常规氧疗者(RR 0.87 [0.45-1.69])和非ICU设置中(RR 0.88 [0.44-1.76])未见降低。未报告与清醒俯卧位相关的严重不良事件。

要点

  • 10项RCT(1985例)汇总显示,清醒俯卧位较仰卧位显著降低总体插管风险(RR 0.84 [95% CI 0.72-0.97])。
  • 入组时接受先进呼吸支持(经鼻高流量氧疗或无创通气)者,清醒俯卧位降低插管需求(RR 0.83 [0.71-0.97])。
  • ICU设置中清醒俯卧位降低插管需求(RR 0.83 [0.71-0.97]),非ICU设置中未显示降低(RR 0.88 [0.44-1.76])。
  • 接受常规氧疗者未显示插管风险降低(RR 0.87 [0.45-1.69])。
  • 未报告与清醒俯卧位相关的严重不良事件;主要结局未见明显偏倚风险和发表偏倚。

适用人群与场景

  • COVID-19相关急性低氧性呼吸衰竭的非插管患者。
  • 排除入组前或入组时已插管的患者、儿科患者(即 younger than 18 years)、对照组不含仰卧位的研究。

研究设计与关键结果

  • 研究类型:系统评价与Meta分析,纳入RCT和观察性研究(对照组需含仰卧位),检索MEDLINE、Embase、PubMed、Web of Science、Scopus、MedRxiv、BioRxiv和ClinicalTrials.gov,检索时间2020年1月1日至2021年11月8日。
  • 共纳入29项研究:10项RCT(1985例)和19项观察性研究(2669例);主要分析基于RCT,观察性研究用于敏感性分析。
  • 主要结局:10项RCT中,清醒俯卧位较仰卧位显著降低总体人群插管风险(RR 0.84 [95% CI 0.72-0.97])。
  • 亚组:入组时接受先进呼吸支持(经鼻高流量氧疗或无创通气)者插管风险降低(RR 0.83 [0.71-0.97]);ICU设置中插管风险降低(RR 0.83 [0.71-0.97]);接受常规氧疗者未显示降低(RR 0.87 [0.45-1.69]);非ICU设置中未显示降低(RR 0.88 [0.44-1.76])。
  • 安全性:未报告与清醒俯卧位相关的严重不良事件。
  • 偏倚:主要结局未见明显偏倚风险和发表偏倚。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入10项RCT和19项观察性研究;采用GRADE方法评估证据质量和推荐强度。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对于COVID-19相关急性低氧性呼吸衰竭且需要先进呼吸支持或在ICU治疗的患者,应使用清醒俯卧位。
  • 对于接受常规氧疗或非ICU设置的患者,RCT汇总未显示插管风险降低。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Awake prone positioning has been broadly utilised for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure, but the results from published randomised controlled trials (RCTs) in the past year are contradictory. We aimed to systematically synthesise the outcomes associated with awake prone positioning, and evaluate these outcomes in relevant subpopulations.

METHODS: In this systematic review and meta-analysis, two independent groups of researchers searched MEDLINE, Embase, PubMed, Web of Science, Scopus, MedRxiv, BioRxiv, and ClinicalTrials.gov for RCTs and observational studies (with a control group) of awake prone positioning in patients with COVID-19-related acute hypoxaemic respiratory failure published in English from Jan 1, 2020, to Nov 8, 2021. We excluded trials that included patients intubated before or at enrolment, paediatric patients (ie, younger than 18 years), or trials that did not include the supine position in the control group. The same two independent groups screened studies, extracted the summary data from published reports, and assessed the risk of bias. We used a random-effects meta-analysis to pool individual studies. We used the Grading of Recommendations Assessment, Development, and Evaluation approach to assess the certainty and quality of the evidence. The primary outcome was the reported cumulative intubation risk across RCTs, and effect estimates were calculated as risk ratios (RR;95% CI). The analysis was primarily conducted on RCTs, and observational studies were used for sensitivity analyses. No serious adverse events associated with awake prone positioning were reported. The study protocol was prospectively registered with PROSPERO, CRD42021271285.

FINDINGS: A total of 1243 studies were identified, we assessed 138 full-text articles and received the aggregated results of three unpublished RCTs; therefore, after exclusions, 29 studies were included in the study. Ten were RCTs (1985 patients) and 19 were observational studies (2669 patients). In ten RCTs, awake prone positioning compared with the supine position significantly reduced the need for intubation in the overall population (RR 0·84 [95% CI 0·72-0·97]). A reduced need for intubation was shown among patients who received advanced respiratory support (ie, high-flow nasal cannula or non-invasive ventilation) at enrolment (RR 0·83 [0·71-0·97]) and in intensive care unit (ICU) settings (RR 0·83 [0·71-0·97]) but not in patients receiving conventional oxygen therapy (RR 0·87 [0·45-1·69]) or in non-ICU settings (RR 0·88 [0·44-1·76]). No obvious risk of bias and publication bias was found among the included RCTs for the primary outcome.

INTERPRETATION: In patients with COVID-19-related acute hypoxaemic respiratory failure, awake prone positioning reduced the need for intubation, particularly among those requiring advanced respiratory support and those in ICU settings. Awake prone positioning should be used in patients who have acute hypoxaemic respiratory failure due to COVID-19 and require advanced respiratory support or are treated in the ICU.

FUNDING: OpenAI, Rice Foundation, National Institute for Health Research, and Oxford Biomedical Research Centre.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Li J, Luo J, Pavlov I, et al. Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis. Lancet Respir Med. 2022. PMID: 35305308. doi:10.1016/S2213-2600(22)00043-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。